Trump administration probe could upend widely used transgender youth treatment guidelines

The case could determine whether the medical guidance that shaped transgender treatment for thousands of children was built on solid evidence or agenda-driven speculation.

FTC Chairman Andrew Ferguson said the lawsuit is a consumer-protection case focused on whether families were properly informed about the risks and benefits of these treatments.

At the center of the lawsuit are allegations that WPATH publicly described its Standards of Care as evidence-based and rooted in expert consensus while some of the organization's own leaders privately acknowledged limitations in the available evidence.

It also references comments from Dr. Amy Tishelman, lead author of the organization's chapter on children, who acknowledged in an NPR interview that there was no established "research basis" for determining the best assessments or treatments for "transgender youth."

Kurt Miceli, chief medical officer for Do No Harm, a medical ethics advocacy organization, said the allegations raise serious questions about how the organization's guidelines were developed.

Federal regulators allege that many of the clinicians and surgeons who helped draft WPATH's guidelines had financial and professional interests tied to the treatments being recommended.

"What WPATH did was stack the deck with folks who had a financial invested interest in promoting pediatric medical transition, and subsequently you get guidelines that push hormones, puberty blockers, and surgeries," Miceli said.

Among the most serious allegations are claims that WPATH promoted pediatric transition procedures as "lifesaving" despite insufficient evidence that such interventions reduce suicide risk.

The complaint cites instances in which parents were allegedly asked whether they would "rather have a live daughter or a dead son" when considering treatment options for their children.

"When WPATH says that these are life-saving interventions, and then we hear physicians tell parents, 'Would you rather have a dead son or a living daughter?', and we hear that line repeated, which again is not supported by evidence by any means whatsoever," Miceli said.

"The benefits that WPATH is claiming are there actually aren't," Miceli told Fox News Digital. "In fact, the benefits are a very low certainty."

WPATH rejected the allegations Wednesday, calling the lawsuit politically motivated and legally flawed.

"This is the second time this year the Trump Administration has abused the authority of its agencies to interfere with Americans' rights to seek and obtain the healthcare that should be decided between a patient and their physician," the organization said in a statement.

Miceli said the lawsuit should prompt a broader review by medical organizations that have relied on WPATH's guidance.